Wikidata

(Q45945230)

English

Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.

scientific article published on 20 October 2014

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25332247
retrieved
18 December 2017
reference URL
http://europepmc.org/abstract/MED/25332247

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45945230&oldid=1686981933"